Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
MO08 - NSCLC - Early Stage
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 12
- Moderators:K. Nakagawa
- Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Gallery B, Level 1
-
+
MO08.06 - DISCUSSANT
16:40 - 16:55 | Author(s): T. Le Chevalier
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO13 - SCLC I
- Type: Mini Oral Abstract Session
- Track: Medical Oncology
- Presentations: 11
- Moderators:C.K. Liam
- Coordinates: 10/29/2013, 10:30 - 12:00, Bayside 201 - 203, Level 2
-
+
MO13.09 - Small cell lung cancer in daily practice; SCOT registry (Small cell lung Cancer treatment and OuTcome)
11:20 - 11:25 | Author(s): P.E. Postmus
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
O17 - Anatomical Pathology I
- Type: Oral Abstract Session
- Track: Pathology
- Presentations: 8
- Moderators:K. Jones
- Coordinates: 10/29/2013, 10:30 - 12:00, Bayside 105, Level 1
-
+
O17.01 - Prognostic and predictive value of a new IASLC/ATS/ERS lung adenocarcinoma classification in a pooled analysis of four adjuvant chemotherapy trials: a LACE-Bio study
10:30 - 10:40 | Author(s): E.M. Brambilla
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
O27 - Clinical Trials and Practice
- Type: Oral Abstract Session
- Track: Other Topics
- Presentations: 8
- Moderators:J.S. Lee
- Coordinates: 10/29/2013, 16:15 - 17:45, Bayside Auditorium A, Level 1
-
+
O27.07 - Molecular multidisciplinary tumor board (MMTB) for lung cancer patients: 2-year experience report
17:20 - 17:30 | Author(s): B. Besse
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P3.18 - Poster Session 3 - Pathology
- Type: Poster Session
- Track: Pathology
- Presentations: 21
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.18-018 - Results of upfront genomic testing in non-small cell lung cancer (NSCLC) patients (MSN study)
09:30 - 09:30 | Author(s): D. Planchard
- Abstract
Loading...
-
+
MO22 - Advanced Disease and Outcomes
- Type: Mini Oral Abstract Session
- Track: Surgery
- Presentations: 12
- Moderators:T. Yano
- Coordinates: 10/30/2013, 10:30 - 12:00, Parkside 110 A+B, Level 1
-
+
MO22.08 - Surgical Resection of Stage IIIA-N2 non-small cell lung cancer: Should we still talk about the futile thoracotomy?
11:15 - 11:20 | Author(s): O. Mercier
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
MO25 - NSCLC - Combined Modality Therapy II
- Type: Mini Oral Abstract Session
- Track: Mesothelioma
- Presentations: 11
- Moderators:T. Le Chevalier
- Coordinates: 10/30/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
-
+
MO25.01 - Interim analysis of the Spanish Lung Cancer Group (SLCG) randomized phase II trial of thoracic radiotherapy (RT) concurrent with cisplatin (P) plus oral vinorelbine (OV) or etoposide (E) for unresectable locally advanced (LA) stage III non-small cell lung cancer (NSCLC). (GECP10/02).
10:30 - 10:35 | Author(s): D. Isla
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO25.02 - Thoracic Radiotherapy With or Without Concurrent Daily Low-Dose Carboplatin in Elderly Patients With Locally Advanced Non-small Cell Lung Cancer: Updated Results of the JCOG0301 and Pooled Analysis With the JCOG9812 Trial.
10:35 - 10:40 | Author(s): S. Atagi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO25.03 - Safety data from a Phase II study of pemetrexed (PEM) and cisplatin (CIS) with concurrent thoracic radiation after PEM+CIS induction in patients with unresectable locally advanced (LA) Non Squamous Non-Small Cell Lung Cancer (NS-NSCLC)
10:40 - 10:45 | Author(s): P. Garrido
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO25.04 - Phase II study comparing Cisplatin/Etoposide and weekly Paclitaxol/Carboplatin regimens with concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung cancer
10:45 - 10:50 | Author(s): J. Liang
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO25.05 - DISCUSSANT
10:50 - 11:05 | Author(s): R.P. Abratt
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO25.06 - Phase I/II trial of recombinant human endostatin in combination with concurrent chemo-radiotherapy in the patients with stage III non-small-cell lung cancer
11:05 - 11:10 | Author(s): M. Chen
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO25.07 - Early onset body weight loss during concurrent chemo-radiotherapy for non-small cell lung cancer is not due to dysphagia or reduced calorie intake
11:10 - 11:15 | Author(s): C. Op Den Kamp
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO25.08 - Impact of Pretretment Leukocytosis on Prognosis in Locally Advanced Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy
11:15 - 11:20 | Author(s): E. Topkan
- Abstract
Loading... -
+
MO25.09 - A Phase II study of 18F-FDG PET guided optimization of neoadjuvant chemotherapy for resectable non-small cell lung cancer
11:20 - 11:25 | Author(s): J.E. Chaft
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO25.10 - A Phase II trial of mid-treatment FDG-PET adaptive, individualized radiation therapy plus concurrent chemotherapy in patients with inoperable non-small cell lung cancer (NSCLC)
11:25 - 11:30 | Author(s): F.(. Kong
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
MO25.11 - DISCUSSANT
11:30 - 11:45 | Author(s): K. Kubota
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
